We are live on ! Find out more
FBB

Fulton Breakefield Broenniman Portfolio holdings

AUM $1.7B
1-Year Est. Return 23.97%
This Fund
S&P 500
This Quarter Est. Return
-5.69%
1 Year Est. Return
+23.97%
3 Year Est. Return
+68.05%
5 Year Est. Return
+78.87%
10 Year Est. Return
+273.12%
AUM
$1.14B
AUM Growth
-$213M
Cap. Flow
-$137M
Cap. Flow %
-12.04%
Top 10 Hldgs %
31.34%
Holding
202
New
15
Increased
75
Reduced
58
Closed
44

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$4.47M
2
NFLX icon
Netflix
NFLX
+$4.19M
3
TSLA icon
Tesla
TSLA
+$3.23M
4
ABBV icon
AbbVie
ABBV
+$2.58M
5
CRM icon
Salesforce
CRM
+$2.17M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$61.3M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$31.1M
3
AMZN icon
Amazon
AMZN
+$25.2M
4
HRB icon
H&R Block
HRB
+$21M
5
RTX icon
RTX Corp
RTX
+$12.5M

Sector Composition

Rank Sector Weight
1 Technology 15.76%
2 Healthcare 12.26%
3 Financials 9.05%
4 Consumer Discretionary 6.47%
5 Consumer Staples 5.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GS icon
151
Goldman Sachs
GS
$303B
$223K 0.02%
+674
New +$238K
SPGI icon
152
S&P Global
SPGI
$120B
$217K 0.02%
+528
New +$215K
RNP icon
153
Cohen & Steers REIT and Preferred and Income Fund
RNP
$989M
$215K 0.02%
8,000
CI icon
154
Cigna
CI
$74.6B
$214K 0.02%
892
ITW icon
155
Illinois Tool Works
ITW
$84.5B
$211K 0.02%
1,007
-206
-17% -$46.1K
VEU icon
156
Vanguard FTSE All-World ex-US ETF
VEU
$70.2B
$207K 0.02%
3,589
+1
+0% +$59
WTS icon
157
Watts Water Technologies
WTS
$13.1B
$200K 0.02%
1,431
-275
-16% -$43.1K
DFTX
158
Definium Therapeutics
DFTX
$6.12B
$20K ﹤0.01%
1,183
+333
+39% +$5.78K
AAPL icon
159
Apple
AAPL
$4.57T
-345,311
Closed -$61.3M
ABT icon
160
Abbott
ABT
$187B
-2,709
Closed -$381K
ADI icon
161
Analog Devices
ADI
$190B
-2,617
Closed -$460K
AEP icon
162
American Electric Power
AEP
$68.4B
-4,598
Closed -$409K
AKAM icon
163
Akamai
AKAM
$15.9B
-3,623
Closed -$424K
ALB icon
164
Albemarle
ALB
$15.5B
-7,078
Closed -$1.66M
AMAT icon
165
Applied Materials
AMAT
$428B
-1,645
Closed -$259K
AMGN icon
166
Amgen
AMGN
$222B
-8,353
Closed -$1.88M
AMZN icon
167
Amazon
AMZN
$2.96T
-151,340
Closed -$25.2M
APD icon
168
Air Products & Chemicals
APD
$67.6B
-852
Closed -$259K
ATO icon
169
Atmos Energy
ATO
$28.8B
-4,979
Closed -$522K
AXP icon
170
American Express
AXP
$230B
-2,349
Closed -$384K
BA icon
171
Boeing
BA
$185B
-9,075
Closed -$1.83M
BAX icon
172
Baxter International
BAX
$14.2B
-130,583
Closed -$11.2M
BRK.B icon
173
Berkshire Hathaway Class B
BRK.B
$1.13T
-103,934
Closed -$31.1M
CRL icon
174
Charles River Laboratories
CRL
$12.8B
-1,163
Closed -$438K
DKS icon
175
Dick's Sporting Goods
DKS
$18.7B
-4,159
Closed -$478K

Similar funds

Fulton Breakefield Broenniman's Q1 2022 Portfolio in Review

As of Q1 2022, Fulton Breakefield Broenniman held 202 positions worth $1.14B, down 16% from $1.35B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Fulton Breakefield Broenniman withdrew a net $137M in Q1 2022, closing 44 positions and reducing 58 holdings. Its most notable exit was Apple, an estimated $61.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Fulton Breakefield Broenniman opened a new position in Vanguard Russell 2000 ETF worth $796K.

  • Fulton Breakefield Broenniman's largest Q1 2022 buy was Vanguard Russell 2000 ETF: 9,612 shares worth $796K.
  • Fulton Breakefield Broenniman added most to NVIDIA in Q1 2022, an estimated $4.47M increase.
  • Fulton Breakefield Broenniman's biggest Q1 2022 reduction was Chevron, cutting an estimated $2.1M.
  • Fulton Breakefield Broenniman fully exited Apple in Q1 2022, selling an estimated $61.3M.
  • Fulton Breakefield Broenniman's ten largest holdings make up 31% of its $1.14B portfolio in Q1 2022.
  • Fulton Breakefield Broenniman opened 15 new positions and closed 44 in Q1 2022.
  • Fulton Breakefield Broenniman's portfolio value fell 16% quarter-over-quarter to $1.14B.

Based on Fulton Breakefield Broenniman's 13F filing for Q1 2022, filed 27 Apr 2022.